The clinical uroselectivity of alfuzosin is not significantly affected by the age of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

  1. Sánchez-Chapado, M.
  2. Guil, M.
  3. Badiella, L.I.
  4. Fernández-Hernando, N.
  5. Alfaro, V.
Aldizkaria:
BJU International

ISSN: 1464-4096

Argitalpen urtea: 2000

Alea: 86

Zenbakia: 4

Orrialdeak: 432-438

Mota: Artikulua

DOI: 10.1046/J.1464-410X.2000.00834.X GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak